THE FUNDAMENTAL CONCEPTS: PRESSURE, FLOW AND ISCHEMIA

Saturday, February 25, 2023

2:00 PM – 3:15 PM ET

Moderator(s)

Tariq Enezate, MD

Interventional Cardiology Faculty
OSF-Urbana
Urbana, Illinois, United States

No relationships to disclose
Javier Escaned, MD, PhD (he/him/his)

Head of Section (Interventional Cardiology) / Dept. of Cardiology
Hospital Clínico San Carlos
Madrid, Madrid, Spain

Disclosure information not submitted.
Allen Jeremias, MD, FSCAI (he/him/his)

Associate Director, Cardiac Cath Lab
St. Francis Hospital, Roslyn, NY
Woodbury, New York, United States

Disclosure(s): Abbott Vascular: Consultant (Ongoing), Educational Grant (Ongoing); Acist Medical: Consultant (Ongoing), Educational Grant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Philips: Consultant (Ongoing), Grant/Research Support (Ongoing), Scientific Advisory Board (Ongoing)
Morton J. Kern, MD, MSCAI, FACC, FAHA

Chief of Cardiology
VA Long Beach Health Care System
Long Beach, California, United States

Disclosure(s): Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic.: Clinical Trial Support (Ongoing), Speakers' Bureau (Ongoing)

Disclosure(s):

Allen Jeremias, MD, FSCAI: Abbott Vascular: Consultant (Ongoing), Educational Grant (Ongoing); Acist Medical: Consultant (Ongoing), Educational Grant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Philips: Consultant (Ongoing), Grant/Research Support (Ongoing), Scientific Advisory Board (Ongoing)

Morton J. Kern, MD, MSCAI, FACC, FAHA: Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic.: Clinical Trial Support (Ongoing), Speakers' Bureau (Ongoing)